Peripheral Vascular Devices Market Scope
Peripheral vascular devices market includes IVC filters, angiography catheters, EVAR stent-grafts, hemodynamic flow alteration, and plague modification devices are used for treating peripheral arterial or coronary arterial disease and also used in the peripheral endovascular and coronary procedure. Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels, due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated.
The Peripheral Vascular Devices market study is segmented by Type (Peripheral Vascular Stents, PTA Balloon Catheter, Embolic Protection Device, Aortic Stent Graft and Surgical Artificial Transplant), by Application (Peripheral Blood Vessels Damaged and Peripheral Blood Vessels Blockage) and major geographies with country level break-up.
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Peripheral Vascular Devices market throughout the predicted period.
Medtronic (Ireland), Boston Scientific Corporation (United States), Abbott (United States), Cardinal Health (United States), iVascular (Spain), Becton, Dickinson and Company (United States), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore) and BIOTRONIK SE & Co. KG (Germany) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Peripheral Vascular Devices market by Type, Application and Region.
On the basis of geography, the market of Peripheral Vascular Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In 2020, Terumo has received US FDA approval for its TREO Abdominal Aortic Stent-Graft System
- Growing demand for peripheral vascular devices
- Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases
- Increased government spending's on medical sector
- Product failures and recalls
- Availability of alternative treatments
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Hospitals and Labs, Government Regulatory and Research Organizations and End-Use Industries
Frequently asked questions:1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Peripheral Vascular Devices Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.